Pure Global

PROPHYLACTIC ERGOMETRIN VERSUS OXYTOCIN IN THIRD STAGE - Trial PACTR201105000292708

Access comprehensive clinical trial information for PACTR201105000292708 through Pure Global AI's free database. This Not Applicable trial is sponsored by DR EZEAMA C; LIFE SPECIALIST HOSPITAL, LTD and is currently Completed. The study focuses on Pregnancy and Childbirth; Other.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR201105000292708
Not Applicable
Completed
Trial Details
Pan Africa Clinical Trials Registry • PACTR201105000292708
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
PROPHYLACTIC ERGOMETRIN VERSUS OXYTOCIN IN THIRD STAGE
PROPHYLACTIC ERGOMETRINE VERSUS OXYTOCIN FOR WOMEN IN THE THIRD STAGE OF LABOUR: A DOUBLE-BLIND, RANDOMIZED TRIAL

Study Focus

Sponsor & Location

DR EZEAMA C; LIFE SPECIALIST HOSPITAL, LTD

DR EZEAMA C

Nigeria

Timeline & Enrollment

Not Applicable

Jan 01, 1900

Jan 01, 1900

Summary

Postpartum haemorrhage (PPH) is an important cause of maternal mortality worldwide.However, in our environment where PPH is the leading cause of maternal death, in selected patients, the benefit might outweigh the risk, and so ergometrine may be preferred.This trial therefore is aimed to determine the effectiveness and safety of ergometrine in comparison with oxytocin as conventional uterotonic agents for use in the third stage of labour.

ICD-10 Classifications

Pregnancy, childbirth and the puerperium
Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
Fetus and newborn affected by other complications of labour and delivery
Fetus and newborn affected by other specified complications of labour and delivery
Fetus and newborn affected by other maternal complications of pregnancy

Data Source

Pan Africa Clinical Trials Registry

PACTR201105000292708

Non-Device Trial